Task: Answer the multiple-choice question.
Query: Which drug exhibits a 20.079\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
b: CC(=O)N(C)c1nnc(-c2ccccn2)s1
Answer: a. CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
3-(4-methylpiperazin-1-yl)-N-[(E)-pyridin-2-ylmethylideneamino]propanamide